New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Skeletal muscle is essential for normal bodily function and the loss of skeletal muscle (i.e. muscle atrophy/wasting) can have a major impact on mobility, whole-body metabolism, disease resistance, and quality of life. Thus, there is a clear need for the development of therapies that can prevent the loss, or increase, of skeletal muscle mass. However, in order to develop such therapies, we will first have to develop a thorough understanding of the molecular mechanisms that regulate muscle mass. Fortunately, our knowledge is rapidly advancing, and in this review, we will summarize recent studies that have expanded our understanding of the roles that Smad signaling and the synthesis of phosphatidic acid play in the regulation of skeletal muscle mass.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Assessing ribosome biogenesis in living human skeletal muscle presents profound methodological hurdles that frequently obscure the entire mechanistic continuum from mechanotransduction to phenotypic adaptation [20,23,30].”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lokireddy, S., McFarlane, C., Ge, X., Zhang, H., Sze, S. K., Sharma, M., & Kambadur, R. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1124 · Cited by 117 · cited 2×
“Furthermore, Smad3 has been found to be necessary for myostatin-induced increases in atrogin-1 expression and atrophy of cultured myotubes [40,41].”
RetractedFord, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 1×
“The PLD1/PAinduced inhibition of these atrophy genes appears to be due to the activation of Akt, possibly via the activation of the rapamycin-insensitive mTOR complex 2 (mTORC2) [76-78].”
BackgroundStitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · cited 1×
“Initial interest in the role of Smad signaling in the regulation of skeletal muscle mass largely stemmed from the discovery that the disruption of the GDF-8 (also known as the myostatin) gene, and the inhibition of myostatin receptor binding, produced marked skeletal muscle hypertrophy [30,31].”
BackgroundMechanisms regulating skeletal muscle growth and atrophy
Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B., & Sandri, M. (2013) · The FEBS Journal · doi:10.1111/febs.12253 · Cited by 1,492 · cited 1×
“Importantly, it has been demonstrated that Smad3 signaling is necessary for the myostatin-induced inhibition of the Akt/mTORC1 pathway [40,50].”
BackgroundCellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284 · cited 1×
“injury-induced immobilization, severe burns, cancer cachexia, aging, heart failure, obesity, diabetes, chronic obstructive pulmonary disease, renal disease, and HIV) and can be induced by changes in a variety of factors, including nutrients, neural activity, cytokines, growth factors, hormones, and mechanical loading…”
BackgroundPhosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055 · cited 3×
“…shown that the stimulation of cells with exogenous PA, or the overexpression of PA-generating enzymes, can activate mTORC1 signaling [62-66], whereas blocking the generation of PA has been reported to inhibit the activation of mTORC1 that occurs in response to various types of stimuli [60,67-70].”
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204291200 · Cited by 908 · cited 1×
“Furthermore, it has since been shown that an increase in myostatin is often associated with skeletal muscle atrophy [32,33] and an increase in Smad3 phosphorylation [34].”
BackgroundInduction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S.-J. (2002) · Science · doi:10.1126/science.1069525 · Cited by 907 · cited 1×
“Furthermore, it has since been shown that an increase in myostatin is often associated with skeletal muscle atrophy [32,33] and an increase in Smad3 phosphorylation [34].”
BackgroundBMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk
Miyazono, K., Maeda, S., & Imamura, T. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.009 · Cited by 887 · cited 1×
“(BMP) and GDF subfamilies [28,29] (Figure 1).”
Lee, R. C., Wang, Z., Heo, M., Ross, R., Janssen, I., & Heymsfield, S. B. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.796 · Cited by 854 · cited 1×
“Furthermore, because skeletal muscle makes up such a large, metabolically active proportion of the body (~45%), it also plays an important role in the regulation of whole-body metabolism (e.g. systemic glucose control) [1,2].”
The regulation of TGFβ signal transduction
Moustakas, A., & Heldin, C.-H. (2009) · Development · doi:10.1242/dev.030338 · Cited by 832
Signaling in Muscle Atrophy and Hypertrophy
Sandri, M. (2008) · Physiology · doi:10.1152/physiol.00041.2007 · Cited by 827 · cited 1×
“injury-induced immobilization, severe burns, cancer cachexia, aging, heart failure, obesity, diabetes, chronic obstructive pulmonary disease, renal disease, and HIV) and can be induced by changes in a variety of factors, including nutrients, neural activity, cytokines, growth factors, hormones, and mechanical loading…”
BackgroundMyostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00105.2009 · Cited by 792 · cited 3×
“Furthermore, Smad3 has been found to be necessary for myostatin-induced increases in atrogin-1 expression and atrophy of cultured myotubes [40,41].”
BackgroundSrikanthan, P., & Karlamangla, A. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0435 · Cited by 785 · cited 2×
“muscle atrophy) can have a major impact on mobility, whole-body metabolism, disease resistance, and quality of life [3-5].”
BackgroundSignaling functions of phosphatidic acid
WANG, X., DEVAIAH, S., ZHANG, W., & WELTI, R. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.01.005 · Cited by 757 · cited 4×
“Instead, it was shown that passive stretch induces an increase in DAG, suggesting that there could be corresponding increases in DGK activity.”
InfluentialGlucocorticoid-Induced Skeletal Muscle Atrophy
Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.036 · Cited by 705 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundProtein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome
Sandri, M. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.023 · Cited by 689 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundGonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571 · cited 1×
“Furthermore, it has since been shown that an increase in myostatin is often associated with skeletal muscle atrophy [32,33] and an increase in Smad3 phosphorylation [34].”
BackgroundSignaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundSmad2 and 3 transcription factors control muscle mass in adulthood
Sartori, R., Milan, G., Patron, M., Mammucari, C., Blaauw, B., Abraham, R., & Sandri, M. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00104.2009 · Cited by 517 · cited 1×
“(2009), who showed that the overexpression of a constitutively active mutant of ALK5 (caALK5) increased the promoter activity of the musclespecific ubiquitin proteasome E3 ligase atrogin-1 gene and inducedmuscle fiber atrophy via a Smad3-dependent mechanism [39].”
Goodman, C. A., Mabrey, D. M., Frey, J. W., Miu, M. H., Schmidt, E. K., Pierre, P., & Hornberger, T. A. (2011) · The FASEB Journal · doi:10.1096/fj.10-168799 · Cited by 475 · cited 1×
“As the activation of mTORC1 signaling is known to be sufficient to increase protein synthesis and induce muscle fiber hypertrophy [75], these data suggest that PLD1-derived PA controls skeletalmusclemass, in part, via the regulationofmTORC1 and protein synthesis.”
BackgroundSelf-citationBMP signaling controls muscle mass
Sartori, R., Schirwis, E., Blaauw, B., Bortolanza, S., Zhao, J., Enzo, E., Stantzou, A., Mouisel, E., Toniolo, L., Ferry, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2772 · Cited by 467 · cited 11×
“Instead, this protective effect appears to be due to the suppression of musclespecific ubiquitin proteasome E3 ligases, including the recently identified MUSA1 (also known as Fbxo30) [56,57].”
InfluentialMyogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases
Moresi, V., Williams, A. H., Meadows, E., Flynn, J. M., Potthoff, M. J., McAnally, J., Shelton, J. M., Backs, J., Klein, W. H., Richardson, J. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.004 · Cited by 444
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & Gonzalez-Cadavid, N. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410 · cited 1×
“Other studies have also shown that increased myostatin is sufficient to induce a decrease in protein synthesis, possibly by promoting the atrogin-1-mediated degradation of ribosomal proteins and translation initiation factors or via the inhibition of signaling through the protein kinase B (Akt) and mechanistic target…”
BackgroundRole of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Lynch, G. S., & Ryall, J. G. (2008) · Physiological Reviews · doi:10.1152/physrev.00028.2007 · Cited by 410 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundFast/Glycolytic Muscle Fiber Growth Reduces Fat Mass and Improves Metabolic Parameters in Obese Mice
Izumiya, Y., Hopkins, T., Morris, C., Sato, K., Zeng, L., Viereck, J., Hamilton, J. A., Ouchi, N., LeBrasseur, N. K., & Walsh, K. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.003 · Cited by 395 · cited 1×
“Furthermore, because skeletal muscle makes up such a large, metabolically active proportion of the body (~45%), it also plays an important role in the regulation of whole-body metabolism (e.g. systemic glucose control) [1,2].”
How the Smads regulate transcription
Ross, S., & Hill, C. S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.09.006 · Cited by 383 · cited 1×
“Phosphorylated Smad2 or 3 can then form a heterotrimeric complex with another Smad2 or 3, and a Smad4, and the resulting complex translocates to the nucleus to regulate gene transcription by associating with various transcription factors, co-activators, or co-repressors [36] (Figure 1).”
BackgroundThe benefits of strength training for older adults
SEGUIN, R. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(03)00177-6 · Cited by 354 · cited 1×
“muscle atrophy) can have a major impact on mobility, whole-body metabolism, disease resistance, and quality of life [3-5].”
BackgroundThe role of myostatin in muscle wasting: an overview
Elkina, Y., von Haehling, S., Anker, S. D., & Springer, J. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0035-5 · Cited by 348 · cited 2×
“The activation of ActRIIB/IIA receptors leads to the recruitment and activation of serine/threonine type 1 receptor kinases called activin receptor-like kinase-4 and -5 (ALK4 and ALK5), which phosphorylate the transcription factors Smad2 and 3 [35].”
BackgroundLagirand‐Cantaloube, J., Offner, N., Csibi, A., Leibovitch, M. P., Batonnet‐Pichon, S., Tintignac, L. A., Segura, C. T., & Leibovitch, S. A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.52 · Cited by 328 · cited 1×
“Other studies have also shown that increased myostatin is sufficient to induce a decrease in protein synthesis, possibly by promoting the atrogin-1-mediated degradation of ribosomal proteins and translation initiation factors or via the inhibition of signaling through the protein kinase B (Akt) and mechanistic target…”
BackgroundMyostatin/activin pathway antagonism: molecular basis and therapeutic potential
Han, H. Q., Zhou, X., Mitch, W. E., & Goldberg, A. L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.019 · Cited by 314 · cited 1×
“For further background information on these two areas of investigation, the reader is referred to the following reviews: [23-27].”
BackgroundHornberger, T. A., Chu, W. K., Mak, Y. W., Hsiung, J. W., Huang, S. A., & Chien, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600678103 · Cited by 312 · cited 4×
“Since then, numerous studies have shown that the stimulation of cells with exogenous PA, or the overexpression of PA-generating enzymes, can activate mTORC1 signaling [62-66], whereas blocking the generation of PA has been reported to inhibit the activation of mTORC1 that occurs in response to various types of stimuli…”
BackgroundInfluentialSelf-citationPromiscuity and specificity in BMP receptor activation
Mueller, T. D., & Nickel, J. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.043 · Cited by 289 · cited 1×
“BMPRIA [ALK3], BMPRIB [ALK6], and ActRIa [ALK2]), which, in turn, leads to the phosphorylation of Smads 1, 5, and 8 [55] (Figure 1).”
BackgroundAmirouche, A., Durieux, A.-C., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., Bigard, X., Peinnequin, A., & Freyssenet, D. (2009) · Endocrinology · doi:10.1210/en.2008-0959 · Cited by 282 · cited 1×
“Other studies have also shown that increased myostatin is sufficient to induce a decrease in protein synthesis, possibly by promoting the atrogin-1-mediated degradation of ribosomal proteins and translation initiation factors or via the inhibition of signaling through the protein kinase B (Akt) and mechanistic target…”
BackgroundSu, W., Yeku, O., Olepu, S., Genna, A., Park, J.-S., Ren, H., Du, G., Gelb, M. H., Morris, A. J., & Frohman, M. A. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053298 · Cited by 250 · cited 2×
“Thus, we re-examined whether the mechanically induced increase in PA requires PLD by using a small-molecule inhibitor of PLD called 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) [80].”
O’Neil, T. K., Duffy, L. R., Frey, J. W., & Hornberger, T. A. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.173609 · Cited by 227
Self-citationThe bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
Winbanks, C. E., Chen, J. L., Qian, H., Liu, Y., Bernardo, B. C., Beyer, C., Watt, K. I., Thomson, R. E., Connor, T., Turner, B. J., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211134 · Cited by 225 · cited 11×
“Instead, this protective effect appears to be due to the suppression of musclespecific ubiquitin proteasome E3 ligases, including the recently identified MUSA1 (also known as Fbxo30) [56,57].”
InfluentialProtein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass
Frost, R. A., & Lang, C. H. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00089.2007 · Cited by 200
Regulation of mTOR by Phosphatidic Acid?
Foster, D. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3016 · Cited by 190 · cited 4×
“Instead, it was shown that passive stretch induces an increase in DAG, suggesting that there could be corresponding increases in DGK activity.”
InfluentialRecent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass
Goodman, C. A., Mayhew, D. L., & Hornberger, T. A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.013 · Cited by 180 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundSelf-citationVeverka, V., Crabbe, T., Bird, I. N., Lennie, G., Muskett, F. W., Taylor, R. J., & Carr, M. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210693 · Cited by 176 · cited 1×
“Mechanistically, it has been reported that PA can directly activatemTORC1 kinase activity in vitro and this appears to be due to its ability to bind to the FKBP12-rapamycin binding (FRB) domain of mTOR [60,65,71,72].”
BackgroundmTOR Signaling and the Molecular Adaptation to Resistance Exercise
BODINE, S. C. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233797.24035.35 · Cited by 171 · cited 1×
“injury-induced immobilization, severe burns, cancer cachexia, aging, heart failure, obesity, diabetes, chronic obstructive pulmonary disease, renal disease, and HIV) and can be induced by changes in a variety of factors, including nutrients, neural activity, cytokines, growth factors, hormones, and mechanical loading…”
BackgroundMechanotransduction and the regulation of mTORC1 signaling in skeletal muscle
Hornberger, T. A. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.007 · Cited by 170 · cited 2×
“To date, the number of studies that have examined the role of PAsynthesizing enzymes in skeletal muscle is quite limited (for reviews, see [25,26]); however, two recent studies have significantly expanded our understanding of the role of the PA-synthesizing enzymes, PLD1 and the zeta isoform of DGK (DGKz), in the regu…”
BackgroundSelf-citationTSUCHIDA, K., NAKATANI, M., UEZUMI, A., MURAKAMI, T., & CUI, X. (2008) · Endocrine Journal · doi:10.1507/endocrj.kr-110 · Cited by 163 · cited 1×
“Smad2 and 3 are also phosphorylated in response to TGF-b and activin binding to TGF-b type II receptors (TGF-bRII) and ActRIIA/IIB receptors which, in turn, leads to the activation of ALK5 and ALK4/7, respectively [37,38] (Figure 1).”
BackgroundYou, J.-S., Lincoln, H. C., Kim, C.-R., Frey, J. W., Goodman, C. A., Zhong, X.-P., & Hornberger, T. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.531392 · Cited by 163
Self-citationGoodman, C. A. (2013) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2013_17 · Cited by 156 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundSelf-citationÁvila-Flores, A., Santos, T., Rincón, E., & Mérida, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412296200 · Cited by 152 · cited 1×
“…studies have shown that the stimulation of cells with exogenous PA, or the overexpression of PA-generating enzymes, can activate mTORC1 signaling [62-66], whereas blocking the generation of PA has been reported to inhibit the activation of mTORC1 that occurs in response to various types of…”
Smad3 Induces Atrogin-1, Inhibits mTOR and Protein Synthesis, and Promotes Muscle Atrophy In Vivo
Goodman, C. A., McNally, R. M., Hoffmann, F. M., & Hornberger, T. A. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1194 · Cited by 138 · cited 4×
“the overexpression of Smad3 may have decreased BMP/Smad1/5/8 signaling) [53].”
BackgroundInfluentialSelf-citationMyostatin signaling regulates Akt activity via the regulation of miR-486 expression
Hitachi, K., Nakatani, M., & Tsuchida, K. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.12.003 · Cited by 137 · cited 2×
“miR29 or miR486 or both) that normally inhibit the translation of the Akt signaling antagonist, phosphatase and tensin homologue (PTEN) [53,54].”
BackgroundYoon, M.-S., Sun, Y., Arauz, E., Jiang, Y., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262816 · Cited by 134 · cited 1×
“Mechanistically, it has been reported that PA can directly activatemTORC1 kinase activity in vitro and this appears to be due to its ability to bind to the FKBP12-rapamycin binding (FRB) domain of mTOR [60,65,71,72].”
BackgroundIdentification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting
Lokireddy, S., Wijesoma, I. W., Sze, S. K., McFarlane, C., Kambadur, R., & Sharma, M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00402.2011 · Cited by 125 · cited 1×
“Combined, these data suggest that myostatin-induced muscle atrophy may be due, in part, to a combinationof Smad3-mediated increases in atrogin-1 expression and the inhibition of Akt/mTORC1 signaling [41,51,52] (Figure 1).”
BackgroundLokireddy, S., Mouly, V., Butler-Browne, G., Gluckman, P. D., Sharma, M., Kambadur, R., & McFarlane, C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00114.2011 · Cited by 121 · cited 1×
“Combined, these data suggest that myostatin-induced muscle atrophy may be due, in part, to a combination of Smad3-mediated increases in atrogin-1 expression and the inhibition of Akt/mTORC1 signaling [41,51,52] (Figure 1).”
Welle, S., Burgess, K., & Mehta, S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90862.2008 · Cited by 117 · cited 1×
“Other studies have also shown that increased myostatin is sufficient to induce a decrease in protein synthesis, possibly by promoting the atrogin-1-mediated degradation of ribosomal proteins and translation initiation factors or via the inhibition of signaling through the protein kinase B (Akt) and mechanistic target…”
BackgroundCharacterization and Regulation of Mechanical Loading‐Induced Compensatory Muscle Hypertrophy
Adams, G. R., & Bamman, M. M. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110066 · Cited by 114
Senf, S. M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00330 · Cited by 110 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundNew insights into the mechanisms of activin action and inhibition
Walton, K. L., Makanji, Y., & Harrison, C. A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.030 · Cited by 110 · cited 1×
“Smad2 and 3 are also phosphorylated in response to TGF-b and activin binding to TGF-b type II receptors (TGF-bRII) and ActRIIA/IIB receptors which, in turn, leads to the activation of ALK5 and ALK4/7, respectively [37,38] (Figure 1).”
BackgroundMicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease
Zacharewicz, E., Lamon, S., & Russell, A. P. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00266 · Cited by 108
Hulmi, J. J., Oliveira, B. M., Silvennoinen, M., Hoogaars, W. M. H., Ma, H., Pierre, P., Pasternack, A., Kainulainen, H., & Ritvos, O. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00389.2012 · Cited by 97 · cited 1×
“Other studies have also shown that increased myostatin is sufficient to induce a decrease in protein synthesis, possibly by promoting the atrogin-1-mediated degradation of ribosomal proteins and translation initiation factors or via the inhibition of signaling through the protein kinase B (Akt) and mechanistic target…”
BackgroundTWEAK and TRAF6 regulate skeletal muscle atrophy
Kumar, A., Bhatnagar, S., & Paul, P. K. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328351c3fc · Cited by 96 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundMyofibrillar protein synthesis in myostatin-deficient mice
Welle, S., Bhatt, K., & Pinkert, C. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2005 · Cited by 93 · cited 1×
“Other studies have also shown that increased myostatin is sufficient to induce a decrease in protein synthesis, possibly by promoting the atrogin-1-mediated degradation of ribosomal proteins and translation initiation factors or via the inhibition of signaling through the protein kinase B (Akt) and mechanistic target…”
BackgroundYou, J. S., Frey, J. W., & Hornberger, T. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047258 · Cited by 90 · cited 2×
“Since then, numerous studies have shown that the stimulation of cells with exogenous PA, or the overexpression of PA-generating enzymes, can activate mTORC1 signaling [62-66], whereas blocking the generation of PA has been reported to inhibit the activation of mTORC1 that occurs in response to various types of stimuli…”
BackgroundSelf-citationRegulation of Ribosomal S6 Kinase 2 by Mammalian Target of Rapamycin
Park, I., Bachmann, R. A., Shirazi, H., & Chen, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204080200 · Cited by 89 · cited 1×
“Indeed, in 2001, PA was shown to activate mTORC1, a master regulator of protein synthesis and cell growth [60,61].”
BackgroundSkeletal Muscle Degenerative Diseases and Strategies for Therapeutic Muscle Repair
Tabebordbar, M., Wang, E. T., & Wagers, A. J. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132450 · Cited by 79 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundTakahara, T., Hara, K., Yonezawa, K., Sorimachi, H., & Maeda, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606087200 · Cited by 69
Regulation of mTOR by phosphatidic acid
Frias, M. A., Hatipoglu, A., & Foster, D. A. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.01.004 · Cited by 64
PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals
Ha, S. H., Kim, D., Kim, I.-S., Kim, J. H., Lee, M. N., Lee, H. J., Jong Heon, K. I. M., Jang, S. K., Suh, P., & Ryu, S. H. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.021 · Cited by 63 · cited 1×
“…shown that the stimulation of cells with exogenous PA, or the overexpression of PA-generating enzymes, can activate mTORC1 signaling [62-66], whereas blocking the generation of PA has been reported to inhibit the activation of mTORC1 that occurs in response to various types of stimuli [60,67-70].”
Sato, T., Hongu, T., Sakamoto, M., Funakoshi, Y., & Kanaho, Y. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00869-12 · Cited by 63
Ljubicic, V., & Jasmin, B. J. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.07.002 · Cited by 58 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundTang, W., Yuan, J., Chen, X., Gu, X., Luo, K., Li, J., Wan, B., Wang, Y., & Yu, L. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.5.626 · Cited by 54
The mechanical activation of mTOR signaling: an emerging role for late endosome/lysosomal targeting
Jacobs, B. L., Goodman, C. A., & Hornberger, T. A. (2014) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-013-9367-4 · Cited by 52 · cited 2×
“To date, the number of studies that have examined the role of PAsynthesizing enzymes in skeletal muscle is quite limited (for reviews, see [25,26]); however, two recent studies have significantly expanded our understanding of the role of the PA-synthesizing enzymes, PLD1 and the zeta isoform of DGK (DGKz), in the regu…”
BackgroundSelf-citationRodriguez, J., Vernus, B., Toubiana, M., Jublanc, E., Tintignac, L., Leibovitch, S., & Bonnieu, A. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23280 · Cited by 44 · cited 1×
“Other studies have also shown that increased myostatin is sufficient to induce a decrease in protein synthesis, possibly by promoting the atrogin-1-mediated degradation of ribosomal proteins and translation initiation factors or via the inhibition of signaling through the protein kinase B (Akt) and mechanistic target…”
BackgroundYanase, Y., Carvou, N., Frohman, M. A., & Cockcroft, S. (2009) · Biochemical Journal · doi:10.1042/bj20091122 · Cited by 37 · cited 1×
“Although 1-butanol has been used as a PLD inhibitor for many years, more recent studies have questioned its specificity by showing that several of the biological effects of 1-butanol cannot be attributed to its effects on the synthesis of PA by PLD [80-82].”
Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling
Jaafar, R., De Larichaudy, J., Chanon, S., Euthine, V., Durand, C., Naro, F., Bertolino, P., Vidal, H., Lefai, E., & Némoz, G. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-55 · Cited by 37
Lynch, G. S. (2004) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2004.00568.x · Cited by 35 · cited 2×
“muscle atrophy) can have a major impact on mobility, whole-body metabolism, disease resistance, and quality of life [3-5].”
BackgroundCa2+‐ and phospholipase D‐dependent and ‐independent pathways activate mTOR signaling
Ballou, L. M., Jiang, Y.-P., Du, G., Frohman, M. A., & Lin, R. Z. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00816-0 · Cited by 34
Jaafar, R., Zeiller, C., Pirola, L., Grazia, A. D., Naro, F., Vidal, H., Lefai, É., & Némoz, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203885 · Cited by 33 · cited 1×
“The PLD1/PAinduced inhibition of these atrophy genes appears to be due to the activation of Akt, possibly via the activation of the rapamycin-insensitive mTOR complex 2 (mTORC2) [76-78].”
BackgroundThe regulation and function of the striated muscle activator of rho signaling (STARS) protein
Wallace, M. A., Lamon, S., & Russell, A. P. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00469 · Cited by 32 · cited 1×
“In recent years, significant progress has been made in identifying potential molecular signaling mechanisms that regulate skeletal muscle mass under a range of different conditions (for recent reviews, see [10-22]).”
BackgroundEffect of postdevelopmental myostatin depletion on myofibrillar protein metabolism
Welle, S. L., Mehta, S., & Burgess, K. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00509.2010 · Cited by 25
The role of myostatin and bone morphogenetic proteins in muscular disorders
Tsuchida, K. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.2.147 · Cited by 24
Verhees, K. J. P., Pansters, N. A. M., Schols, A. M. W. J., & LANGEN, R. C. J. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180011 · Cited by 24
mTOR Signaling and the Molecular Adaptation to Resistance Exercise
Bodine, S. C. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-200505001-01470 · Cited by 22
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
Winbanks, C. E., Chen, J. L., Qian, H., Liu, Y., Bernardo, B. C., Beyer, C., Watt, K. I., Thomson, R. E., Connor, T., Turner, B. J., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.21012oia54 · Cited by 12
Research works printed but not linked: 1
- [79]O'Neil TK Duffy LR Frey JW Hornberger TA The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions J Physiol (Lond) 2009 587 3691 701 10.1113/jphysiol.2009.173609 19470781 PMC2742291 · DOI · Paper page
Cited by
Roberts, M. D., McCarthy, J. J., Hornberger, T. A., Phillips, S. M., Mackey, A. L., Nader, G. A., Boppart, M. D., Kavazis, A. N., Reidy, P. T., Ogasawara, R., et al. (2023) · Physiological Reviews · doi:10.1152/physrev.00039.2022 · Cited by 214
Self-citationDysregulation of skeletal muscle protein metabolism by alcohol
Steiner, J. L., & Lang, C. H. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00006.2015 · Cited by 150
“For instance, Smad signaling is required for the myostatin-mediated inhibition of Akt/ mTORC1 signaling and myotube atrophy, as well as for TGF -induced fiber atrophy (30, 128, 146).”
BackgroundAlcoholic Myopathy: Pathophysiologic Mechanisms and Clinical Implications
Simon, L., Jolley, S. E., & Molina, P. E. (2017) · Alcohol research · doi:10.35946/arcr.v38.2.05 · Cited by 108
“Smad signaling is required for myostatin-mediated inhibition of Akt/mTORC1 signaling, myotube atrophy, and TGF-β–induced fiber atrophy (Goodman and Hornberger 2014; McFarlane et al. 2006), all of which lead to a reduction of muscle Figure 1 Principal effects of chronic alcohol abuse on anabolic and catabolic mechanisms”
Androgen-mediated regulation of skeletal muscle protein balance
Rossetti, M. L., Steiner, J. L., & Gordon, B. S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.031 · Cited by 95
Wen, Y., Dungan, C. M., Mobley, C. B., Valentino, T., von Walden, F., & Murach, K. A. (2021) · Function · doi:10.1093/function/zqab038 · Cited by 75
Metadata
- Authors
- Goodman, C. A., & Hornberger, T. A.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Hornberger, Troy A.
- Venue
- F1000Prime Reports
- Publisher
- Faculty Opinions Ltd
- Published
- 2014-04-01
- Volume
- 6
- Pages
- 20-20
- ISSN
- 2051-7599 (ISSN-L)
- PMC
- PMC3974568
- OpenAlex
- W2095126612
- Cited by
- 30
- References
- 85
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 4
- FWCI
- 0.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- F1000Prime Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Victoria University Research Repository (Victoria University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (AR057347)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21AR063256, R01AR057347)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- Smad signaling, phosphatidic acid, skeletal muscle mass, muscle atrophy, muscle mass regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.